The LEADER study showed that the injectable diabetes drug liraglutide lowered the risk of heart attack, stroke and cardiovascular death, and reduces the odds of renal problems by 22%.
In a recent study, researchers compared the ability of visceral-to-subcutaneous fat area ratio to predict all-cause mortality, compared with overall adiposity.
A recent study investigated the effects of intensive systolic blood pressure treatment on cardiovascular outcomes among participants with prediabetes and normoglycemia.
Previous research has suggested that common household chemicals could disrupt metabolic homeostasis and contribute to obesity. In a recent study, researchers assessed the effects of exposure to common...
Premature birth is known to be associated with risk of endocrine and metabolic complications. In a recent study, researchers examined the impact of early term delivery on long-term endocrine and metabolic...
In a recent study, researchers sought to determine the extent of the effects of adding a small sugar-sweetened beverage to meals with various macronutrient compositions on appetite, energy metabolism, and...
Previous studies have shown that cardiovascular disease risk is highest among patients at or above 140/90 mm Hg. However, a new review may contradict this evidence. To see results of the study, including...
In a recent study, researchers sought to quantify the long-term morbidity and mortality in patients with no early complications following stroke or TIA.
While observational studies have shown an association between high body mass index and cardiometabolic risks, underlying causal associations are less well understood. In a new study, researchers used...
